Sci-Tech Northern Mariana Islands : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Northern Mariana Islands .

Press releases published on September 28, 2026

17 hours ago

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Indeterminate GlobeNewswire

17 hours ago

VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations

Indeterminate GlobeNewswire

17 hours ago

BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team

Indeterminate GlobeNewswire

17 hours ago

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

17 hours ago

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

17 hours ago

NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase

Indeterminate GlobeNewswire

17 hours ago

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

17 hours ago

Green Data Centers and the New Mexico Building and Construction Trades Council Partner to Set a New Standard for Responsible Data Center Development in New Mexico

Indeterminate GlobeNewswire

18 hours ago

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire

18 hours ago

NOTICE TO DISREGARD -- Direct Meds

Indeterminate GlobeNewswire

18 hours ago

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Indeterminate GlobeNewswire

18 hours ago

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire

18 hours ago

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire

Sep. 28, 2026

Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors

Indeterminate GlobeNewswire

Sep. 28, 2026

NVIDIA Launches Open Agent Safety Platform to Secure Agents From Testing to Deployment

Indeterminate GlobeNewswire

Sep. 28, 2026

KAYTUS Introduces AI Managed Service for Data Centers

Indeterminate GlobeNewswire

Sep. 28, 2026

Atos appoints Paul Potgieter as Head of Middle East & Türkiye

Indeterminate GlobeNewswire

Sep. 28, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Indeterminate GlobeNewswire

Sep. 28, 2026

Vocalbeats.AI Supports FutureChina Global Forum 2026 and Advances Practical AI Innovation

Indeterminate GlobeNewswire

Sep. 28, 2026

Alex Bodi and Prof. Dr Dieter Lazik sign a contract for ALPHA WHEY and BODI Energy Drink

Indeterminate GlobeNewswire